Archil Jaliashvili: From Managing Blood to Managing Oxygen Metabolism
Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn:
“Medicine does not need only another incremental improvement.
It needs a medical moonshot.
BHOCmoonshot
Anemia. Ischemia. Every surgery. Recovery. Longevity. Trauma. Organ transplant. Wound healing. Veterinary medicine. Emergency care.
Different clinical fields — but the same physiological bottleneck:
- Oxygen metabolism and perfusion management.
Today, medicine often measures hemoglobin, blood pressure, and flow.
But the real question is deeper:
- Are we delivering enough oxygen to the tissue — at the right time, in the right place, and in the right dose?
The future is not only blood management.
It is controlled oxygenation metabolism transfusion management.
Controlled. Immediate. Targeted. Continuous.
From managing blood to managing oxygen metabolism.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 15:03Francesco Antonio Veneziano: Rethinking Coronary Artery Disease Through Precision Cardiology
-
Nov 15, 2026, 14:37Denise Rezende: 100 Years of von Willebrand Disease and Advances in Diagnosis
-
Nov 15, 2026, 14:22Ahmed Alotaibi: Does Donor Sex Influence Platelet Storage Quality
-
Nov 15, 2026, 14:09Stephen Alerhand: Acute Pulmonary Embolism vs Chronic Pulmonary Hypertension
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice